Tag Archive | "Drugs"

Tags: , , , , ,

PREVIEW-Risks of old, new diet drugs face U.S. scrutiny

Posted on 09 September 2010 by admin

PREVIEW-Risks of old, new diet drugs face U.S. scrutiny
* Panel to recommend if U.S. should OK Arena Pharma pill

Read more on Reuters via Yahoo! Singapore News

Comments Off

Tags: , , , , , , , ,

Diet drugs – Phendimetrazine (Bontril) used by 60% of weight loss doctors surveyed

Posted on 15 August 2010 by admin


60% of weight loss doctors surveyed use the diet drug phendimetrazine (Bontril). It is the third most used diet drug used by these doctors, behind phentermine and diethylpropion (Tenuate) (60% vs 64% vs 97%). Hi, this is Larry Hobbs @ FatNews.com fatnews.com larryhobbs@fatnews.com REFERENCE Hendricks E, Rothman R, Greenway F. How physician obesity specialists use drugs to treat obesity. Obesity (Silver Spring). 2009 Mar 19, published on-line. AUTHOR’S CONTACT INFORMATION Frank L. Greenway Department of Clinical Trials Pennington Biomedical Research Center Louisiana State University System Baton Rouge, Louisiana, USA Frank.Greenway@pbrc.edu Ed Hendricks MD 2310 Professional Dr., St. 200 Roseville, California 95661 (916) 773-1191 phone www.hendricksforhealth.com

Comments (3)

Tags: , , ,

Grow Your Own Drugs ~ Episode 1~ Part 2 of 3

Posted on 10 August 2010 by admin


James Wong, scientist and gardener, takes us on a journey of healing, utilizing natures pantry.

Comments (2)

Tags: , , , , , , , ,

Diet drugs – Meridia (sibutramine) used by 49% of weight loss doctors surveyed

Posted on 10 August 2010 by admin


49% of weight loss doctors surveyed use the diet drug Meridia (sibutramine). It is the fifth most used diet drug used by these doctors. Adipex (phentermine) 97% Tenuate (diethylpropion) 64% Bontril (phendimetrazine) 60% Topamax (topiramate) 50% Meridia (sibutramine) 49% Hi, this is Larry Hobbs @ FatNews.com fatnews.com larryhobbs@fatnews.com REFERENCE Hendricks E, Rothman R, Greenway F. How physician obesity specialists use drugs to treat obesity. Obesity (Silver Spring). 2009 Mar 19, published on-line. AUTHOR’S CONTACT INFORMATION Frank L. Greenway Department of Clinical Trials Pennington Biomedical Research Center Louisiana State University System Baton Rouge, Louisiana, USA Frank.Greenway@pbrc.edu Ed Hendricks MD 2310 Professional Dr., St. 200 Roseville, California 95661 (916) 773-1191 phone www.hendricksforhealth.com

Comments (4)

Advertise Here
Advertise Here